phase one
The Clinical Trials Guru's Dan Sfera on Innovation in Phase 1 Studies and Beyond
July 30 by Andrea CharlesIt’s no secret that pharma and bio are struggling to fill their pipelines. Dan Sfera from The Clinical Trials Guru, joins Andrea Charles from Pharma IQ to discuss specific challenges ...
The Importance of Innovation in Trial Design
August 02 by Pharma IQClinical development is expensive, invariably high risk and at times enormously inefficient, which is most likely the reason why productivity is sliding so rapidly in the pharmaceutical industry. Wh...
Critical Success Factors in Patient Safety Strategies
June 14 by Gabriele DallmannIn this Pharma IQ interview Nabil Al-Tawil, Principal Investigator of the Phase I Unit at Karolinska University Hospital, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation...
Challenges and Benefits of Patient-Based Phase I Trials
May 05 by Pharma IQPharma IQ held a Q&A session with Dr. James Dow, Director of Clinical Pharmacology & DMPK, (OSI) Prosidion to gain a few insights into phase I clinical development and patient-bas...
Improving Biomarker Development Work Flow in Phase I Clinical Development
September 07 by Helen WinsorReto Ossola, Group Leader for Biomarker Research at Biognosys, joins Pharma IQ to discuss the main challenges in biomarker development and some key ways to address these. Ossola offers some best...
Streamlining the Development and Validation Process in Discovery to Phase I Clinical Development
September 05 by Pharma IQReto Ossola, Group Leader for Biomarket Research at Biognosys, joins Helen Winsor from Pharma IQ, to discuss phase I clinical development. He outlines where he sees the main challenges in biomarker de...
Best Practice Tips for Overcoming Obstacles in Biomarker Development
July 29 by Pharma IQHow can we overcome the latest challenges in Biomarker Development? Birgitte Søgaard, Divisional Director for Clinical Pharmacology and Translational Medicine at H Lundbeck A/S, discusses wit...
FDA Concerned About Lack of PI Oversight in Early Phase Clinical Trials
April 26 by Andrea CharlesIn part one of this interview Dan Sfera from The Clinical Trials Guru, speaks to Andrea Charles from Pharma IQ, about the big trends making an impact in clinical research, the FDA'...
Top Tips for Utilising Imaging Techniques in Early Phase Clinical Trials
April 26 by Jan PasschierJan Passchier, Director PET and Radiochemistry, GlaxoSmithKline, talks to Pharma IQ, about the latest developments in imaging techniques and uses, ahead of Pharma IQ's 2nd Annual Innovation...
4 Reasons Why Asia Isn’t Already a Clinical Trials Hub
April 26 by Bryan CamoensDr. Benjamin Co, Medical Director for Otsuka Philippines, explains the globalisation of clinical trials to Pharma IQ's Bryan Camoens. He also touches on the inconsistent research and regulation...